110 related articles for article (PubMed ID: 15370258)
1. Identification of a circulating soluble form of CD80: levels in patients with hematological malignancies.
Hock BD; Starling GC; Patton WN; Salm N; Bond K; McArthur LT; McKenzie JL
Leuk Lymphoma; 2004 Oct; 45(10):2111-8. PubMed ID: 15370258
[TBL] [Abstract][Full Text] [Related]
2. The soluble form of CD83 is present at elevated levels in a number of hematological malignancies.
Hock BD; Haring LF; Steinkasserer A; Taylor KG; Patton WN; McKenzie JL
Leuk Res; 2004 Mar; 28(3):237-41. PubMed ID: 14687618
[TBL] [Abstract][Full Text] [Related]
3. Human plasma contains a soluble form of CD86 which is present at elevated levels in some leukaemia patients.
Hock BD; Patton WN; Budhia S; Mannari D; Roberts P; McKenzie JL
Leukemia; 2002 May; 16(5):865-73. PubMed ID: 11986949
[TBL] [Abstract][Full Text] [Related]
4. Circulating levels and clinical significance of soluble CD40 in patients with hematologic malignancies.
Hock BD; McKenzie JL; Patton NW; Drayson M; Taylor K; Wakeman C; Kantarjian H; Giles F; Albitar M
Cancer; 2006 May; 106(10):2148-57. PubMed ID: 16598754
[TBL] [Abstract][Full Text] [Related]
5. Elevation of plasma soluble T cell costimulatory molecules CTLA-4, CD28 and CD80 in children with allergic asthma.
Ip WK; Wong CK; Leung TF; Lam CW
Int Arch Allergy Immunol; 2005 May; 137(1):45-52. PubMed ID: 15785081
[TBL] [Abstract][Full Text] [Related]
6. Levels of the soluble forms of CD80, CD86, and CD83 are elevated in the synovial fluid of rheumatoid arthritis patients.
Hock BD; O'Donnell JL; Taylor K; Steinkasserer A; McKenzie JL; Rothwell AG; Summers KL
Tissue Antigens; 2006 Jan; 67(1):57-60. PubMed ID: 16451202
[TBL] [Abstract][Full Text] [Related]
7. Elevation of soluble CD307 (IRTA2/FcRH5) protein in the blood and expression on malignant cells of patients with multiple myeloma, chronic lymphocytic leukemia, and mantle cell lymphoma.
Ise T; Nagata S; Kreitman RJ; Wilson WH; Wayne AS; Stetler-Stevenson M; Bishop MR; Scheinberg DA; Rassenti L; Kipps TJ; Kyle RA; Jelinek DF; Pastan I
Leukemia; 2007 Jan; 21(1):169-74. PubMed ID: 17051241
[TBL] [Abstract][Full Text] [Related]
8. Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus.
Wong CK; Lit LC; Tam LS; Li EK; Lam CW
Rheumatology (Oxford); 2005 Aug; 44(8):989-94. PubMed ID: 15870153
[TBL] [Abstract][Full Text] [Related]
9. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y
J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
[TBL] [Abstract][Full Text] [Related]
10. Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition.
Costello RT; Mallet F; Sainty D; Maraninchi D; Gastaut JA; Olive D
Eur J Immunol; 1998 Jan; 28(1):90-103. PubMed ID: 9485189
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of plasma and cell surface co-stimulatory molecules CTLA-4, CD28 and CD86 in adult patients with allergic asthma.
Wong CK; Lun SW; Ko FW; Ip WK; Hui DS; Lam CW
Clin Exp Immunol; 2005 Jul; 141(1):122-9. PubMed ID: 15958078
[TBL] [Abstract][Full Text] [Related]
12. B7 costimulatory molecules from malignant cells in patients with b-cell chronic lymphoproliferative disorders trigger t-cell proliferation.
Trentin L; Perin A; Siviero M; Piazza F; Facco M; Gurrieri C; Galvan S; Adami F; Agostini C; Pizzolo G; Zambello R; Semenzato G
Cancer; 2000 Sep; 89(6):1259-68. PubMed ID: 11002221
[TBL] [Abstract][Full Text] [Related]
13. The role of soluble CD80 in patients with soft tissue tumors.
Matsuyama Y; Asanuma K; Yoshida K; Hagi T; Iino T; Nakamura T; Sudo A
J Orthop Surg Res; 2022 Sep; 17(1):404. PubMed ID: 36064421
[TBL] [Abstract][Full Text] [Related]
14. Plasma concentrations of soluble CTLA-4, CD28, CD80 and CD86 costimulatory molecules reflect disease severity of acute asthma in children.
Ip WK; Wong CK; Leung TF; Lam CW
Pediatr Pulmonol; 2006 Jul; 41(7):674-82. PubMed ID: 16703581
[TBL] [Abstract][Full Text] [Related]
15. Blocking CD40 - CD154 and CD80/CD86 - CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production.
Van Gool SW; Vermeiren J; Rafiq K; Lorr K; de Boer M; Ceuppens JL
Eur J Immunol; 1999 Aug; 29(8):2367-75. PubMed ID: 10458748
[TBL] [Abstract][Full Text] [Related]
16. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
Belov L; de la Vega O; dos Remedios CG; Mulligan SP; Christopherson RI
Cancer Res; 2001 Jun; 61(11):4483-9. PubMed ID: 11389079
[TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of soluble co-stimulatory molecules and adhesion molecules in type 2 diabetic patients with nephropathy.
Wong CK; Ho AW; Tong PC; Yeung CY; Chan JC; Kong AP; Lam CW
J Clin Immunol; 2008 Jan; 28(1):36-43. PubMed ID: 18026823
[TBL] [Abstract][Full Text] [Related]
18. Effects of preactivated autologous T lymphocytes on CD80, CD86 and CD95 expression by chronic lymphocytic leukemia B cells.
Romano C; De Fanis U; Sellitto A; Dalla Mora L; Chiurazzi F; Giunta R; Rotoli B; Lucivero G
Leuk Lymphoma; 2003 Nov; 44(11):1963-71. PubMed ID: 14738151
[TBL] [Abstract][Full Text] [Related]
19. Soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in hematologic malignancies.
Srivastava MD; Srivastava A; Srivastava BI
Leuk Lymphoma; 1994 Jan; 12(3-4):241-51. PubMed ID: 7909467
[TBL] [Abstract][Full Text] [Related]
20. Copper levels in patients with hematological malignancies.
Kaiafa GD; Saouli Z; Diamantidis MD; Kontoninas Z; Voulgaridou V; Raptaki M; Arampatzi S; Chatzidimitriou M; Perifanis V
Eur J Intern Med; 2012 Dec; 23(8):738-41. PubMed ID: 22920946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
